Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-myeloablative Conditioning”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00002515
What this trial is testing

Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer

Who this might be right for
Childhood Germ Cell TumorExtragonadal Germ Cell TumorHead and Neck Cancer+8 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00369226
What this trial is testing

Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Dana-Farber Cancer Institute 45
Testing effectiveness (Phase 2)Looking for participantsNCT07599176
What this trial is testing

Partial Stem Cell Transplant for Sickle Cell Disease From Matched Donors

Who this might be right for
Sickle Cell DiseaseBeta-thalassemia
National Heart, Lung, and Blood Institute (NHLBI) 90
Testing effectiveness (Phase 2)UnknownNCT00129155
What this trial is testing

MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Hematological MalignanciesAllogeneic Transplantation
Hospices Civils de Lyon 30
Testing effectiveness (Phase 2)Study completedNCT00387959
What this trial is testing

Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
LeukemiaLymphoma
Memorial Sloan Kettering Cancer Center 17
Early research (Phase 1)WithdrawnNCT02548468
What this trial is testing

Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma

Who this might be right for
Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Mycosis Fungoides and Sezary SyndromeStage IIB Mycosis Fungoides and Sezary Syndrome+4 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Looking for participantsNCT04083183
What this trial is testing

Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

Who this might be right for
Non-Malignant Neoplasm
Fred Hutchinson Cancer Center 40
Testing effectiveness (Phase 2)Ended earlyNCT00041288
What this trial is testing

Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

Who this might be right for
LeukemiaLymphoma
University of Texas Southwestern Medical Center 10
Testing effectiveness (Phase 2)Study completedNCT02661035
What this trial is testing

Allo HSCT Using RIC for Hematological Diseases

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+15 more
Masonic Cancer Center, University of Minnesota 156
Testing effectiveness (Phase 2)Study completedNCT00665470
What this trial is testing

Chemotherapy Followed by gp100 Lymphocytes and Aldesleukin to Treat Melanoma

Who this might be right for
Skin CancerMetastatic Melanoma
National Cancer Institute (NCI) 10
Not applicableStudy completedNCT00426205
What this trial is testing

GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies

Who this might be right for
Myelodysplastic Syndrome RAEB-I or RAEB-IIRefractory Acute Myeloid LeukemiaRefractory CML Myeloid Blast Crisis
Dana-Farber Cancer Institute 28
Early research (Phase 1)Study completedNCT01634217
What this trial is testing

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+5 more
Masonic Cancer Center, University of Minnesota 16
Testing effectiveness (Phase 2)Study completedNCT01244906
What this trial is testing

Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

Who this might be right for
Hematologic Neoplasms
Northside Hospital, Inc. 26
Testing effectiveness (Phase 2)Study completedNCT01457885
What this trial is testing

Multi-center Study of Myeloablative Allo Stem Cell Transplant for Non-remission AML Using CloBu4 Regimen

Who this might be right for
Acute Myeloblastic Leukemia
University of Michigan Rogel Cancer Center 75
Large-scale testing (Phase 3)Looking for participantsNCT06615050
What this trial is testing

Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 572
Early research (Phase 1)Study completedNCT00063817
What this trial is testing

Reducing the Risk of Transplant Rejection: Simultaneous Kidney and Bone Marrow Transplant

Who this might be right for
End-stage Renal DiseaseRenal TransplantationKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 5
Large-scale testing (Phase 3)Study completedNCT02278887
What this trial is testing

Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
The Netherlands Cancer Institute 168
Testing effectiveness (Phase 2)Study completedNCT00053196
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma+3 more
Alliance for Clinical Trials in Oncology 82
Testing effectiveness (Phase 2)UnknownNCT01811368
What this trial is testing

Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

Who this might be right for
Refractory Non Hodgkin LymphomaRelapsed Non Hodgkin Lymphoma
Joseph Tuscano 20
Next Page